I'm looking for a gap VERY similar drano. Love to
Post# of 72440
Quote:
What NVS paid for a Phase 2 MS drug is 5 times our market cap.
FIVE times. And with royalties and another 200 million of progress payments.
We're about to enter Phase 3 with Brilacidin.
Shorts should be very scared. I hope they are all massively short when a deal is announced.
Remember, one day DNDN closed at 7. The next day it opened at 21.
It could happen for us.